Cargando…
A four‐gene‐based prognostic model predicts overall survival in patients with hepatocellular carcinoma
With the development of new advances in hepatocellular carcinoma (HCC) management and noninvasive radiological techniques, high‐risk patient groups such as those with hepatitis virus are closely monitored. HCC is increasingly diagnosed early, and treatment may be successful. In spite of this progres...
Autores principales: | Long, Junyu, Zhang, Lei, Wan, Xueshuai, Lin, Jianzhen, Bai, Yi, Xu, Weiyu, Xiong, Jianping, Zhao, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237588/ https://www.ncbi.nlm.nih.gov/pubmed/30247807 http://dx.doi.org/10.1111/jcmm.13863 |
Ejemplares similares
-
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019) -
Combination treatment including targeted therapy for advanced hepatocellular carcinoma
por: Lin, Jianzhen, et al.
Publicado: (2016) -
Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019) -
Construction and Investigation of a lncRNA-Associated ceRNA Regulatory Network in Cholangiocarcinoma
por: Long, Junyu, et al.
Publicado: (2019) -
The diagnostic and prognostic role of RhoA in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2019)